Incidence and Spectrum of Acute Kidney Injury in Cirrhotics and Assessment of New Biomarkers as Early Predictors of Acute Kidney Injury
1 other identifier
observational
450
1 country
1
Brief Summary
500 patients with normal renal function will be prospectively studied and incidence, spectrum and natural history of AKI (Acute Kidney Injury) will be observed in them and in 200 patients with abnormal renal function fulfilling AKI (Acute Kidney Injury) criteria will be prospectively studied for 1 year. Also biomarkers will be studied and validated as early predictors of AKI (Acute Kidney Injury).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Dec 2013
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 2013
CompletedFirst Submitted
Initial submission to the registry
December 9, 2013
CompletedFirst Posted
Study publicly available on registry
December 19, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2015
CompletedAugust 13, 2015
November 1, 2014
1.4 years
December 9, 2013
August 11, 2015
Conditions
Outcome Measures
Primary Outcomes (1)
The incidence , spectrum and natural history of Acute Kidney Injury in patients with cirrhosis
Incidence is defined as No. of AKI (Acute Kidney Injury) patients during the follow up period of 1 year. Spectrum is defined as Grading of AKIN (Acute Kidney Injury Network) 1,2,3 in different child status (Child A,Child B and Child C) at the end . Natural History is defined as Occurrence of AKI (Acute Kidney Injury) and its recovery during the follow up period of 1 year.
1 Year
Secondary Outcomes (2)
To study predictive value of Cystatin C in comparison to serum creatinine as early predictor of development and outcome of AKI in a cohort of Cirrhotics.
1 Years
To study predictive value of Cystatin C to determine progression or resolution of Acute Kidney Injury
1 Years
Study Arms (2)
cirrhosis with baseline renal function
500 patients of cirrhosis with normal baseline renal function will be enrolled.
Cirrhosis with Acute Kidney Injury (AKI).
Cirrhotics patients who present with AKI (Acute Kidney Injury) will be enrolled.
Eligibility Criteria
500 patients with normal renal function. 200 patients with abnormal renal function fulfilling AKI (Acute Kidney Injury) criteria will be prospectively studied.
You may qualify if:
- \- Group A: 500 patients of cirrhosis with normal baseline renal function will be enrolled Group B : 200 patients who present with AKI (Acute Kidney Injury) will be enrolled
You may not qualify if:
- Age \< 18 or \> 70 years
- Preexisting Chronic Renal Disease
- Patients with obstructive uropathy.
- Cirrhosis with HCC (HepatoCellular Carcinoma).
- Advanced cardiopulmonary disease
- Pregnancy
- Patients with extrahepatic malignancy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Institute of Liver & Biliary Sciences
New Delhi, National Capital Territory of Delhi, 110070, India
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 9, 2013
First Posted
December 19, 2013
Study Start
December 1, 2013
Primary Completion
May 1, 2015
Study Completion
May 1, 2015
Last Updated
August 13, 2015
Record last verified: 2014-11